234 related articles for article (PubMed ID: 17936447)
21. Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 mice.
Mohseni AH; Razavilar V; Keyvani H; Razavi MR; Khavari-Nejad RA
J Med Virol; 2019 Feb; 91(2):296-307. PubMed ID: 30192395
[TBL] [Abstract][Full Text] [Related]
22. Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein.
Rodríguez-Díaz J; Montava R; Viana R; Buesa J; Pérez-Martínez G; Monedero V
Biotechnol Lett; 2011 Jun; 33(6):1169-75. PubMed ID: 21302132
[TBL] [Abstract][Full Text] [Related]
23. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.
Sáez D; Fernández P; Rivera A; Andrews E; Oñate A
Vaccine; 2012 Feb; 30(7):1283-90. PubMed ID: 22222868
[TBL] [Abstract][Full Text] [Related]
24. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
[TBL] [Abstract][Full Text] [Related]
25. A human papillomavirus type 16 vaccine by oral delivery of L1 protein.
Sasagawa T; Tani M; Basha W; Rose RC; Tohda H; Giga-Hama Y; Azar KK; Yasuda H; Sakai A; Inoue M
Virus Res; 2005 Jun; 110(1-2):81-90. PubMed ID: 15845258
[TBL] [Abstract][Full Text] [Related]
26. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
[TBL] [Abstract][Full Text] [Related]
27. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.
Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR
J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408
[TBL] [Abstract][Full Text] [Related]
28. The immune response to a recombinant Lactococcus lactis oral vaccine against foot-and-mouth disease virus in mice.
Liu X; Qi L; Lv J; Zhang Z; Zhou P; Ma Z; Wang Y; Zhang Y; Pan L
Biotechnol Lett; 2020 Oct; 42(10):1907-1917. PubMed ID: 32385744
[TBL] [Abstract][Full Text] [Related]
29. Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses.
Wang Z; Gao J; Yu Q; Yang Q
Future Microbiol; 2012 Aug; 7(8):1003-10. PubMed ID: 22913358
[TBL] [Abstract][Full Text] [Related]
30. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
[TBL] [Abstract][Full Text] [Related]
31. Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
Kuck D; Leder C; Kern A; Müller M; Piuko K; Gissmann L; Kleinschmidt JA
Vaccine; 2006 Apr; 24(15):2952-65. PubMed ID: 16414157
[TBL] [Abstract][Full Text] [Related]
32. Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.
Marelli B; Perez AR; Banchio C; de Mendoza D; Magni C
J Virol Methods; 2011 Jul; 175(1):28-37. PubMed ID: 21530589
[TBL] [Abstract][Full Text] [Related]
33. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic DNA immunization against multiple papillomavirus types.
Gasparić M; Rubio I; Thönes N; Gissmann L; Müller M
Vaccine; 2007 Jun; 25(23):4540-53. PubMed ID: 17485151
[TBL] [Abstract][Full Text] [Related]
35. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
Lei H; Peng X; Jiao H; Zhao D; Ouyang J
Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
[TBL] [Abstract][Full Text] [Related]
36. [Prokaryotic expression of HPV 16 L1 gene and identification of its immune activity].
Hao DF; Ma ZH; Wang YP; Rexidan ; Zhang FC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):428-31. PubMed ID: 15989783
[TBL] [Abstract][Full Text] [Related]
37. Oral vaccination with the porcine rotavirus VP4 outer capsid protein expressed by Lactococcus lactis induces specific antibody production.
Li YJ; Ma GP; Li GW; Qiao XY; Ge JW; Tang LJ; Liu M; Liu LW
J Biomed Biotechnol; 2010; 2010():708460. PubMed ID: 20625406
[TBL] [Abstract][Full Text] [Related]
38. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
Cheung YK; Cheng SC; Sin FW; Xie Y
Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
[TBL] [Abstract][Full Text] [Related]
39. [Immune response induced by vaccination with pseudotyped rAAV1 expressing HPV16 L1 protein].
Zhou YB; Li ZL; Zhou L; Sheng W; Ma HT; Zeng Y
Bing Du Xue Bao; 2008 Jul; 24(4):300-4. PubMed ID: 18780634
[TBL] [Abstract][Full Text] [Related]
40. Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization.
Ahmed B; Loos M; Vanrompay D; Cox E
Vaccine; 2014 Jun; 32(31):3909-16. PubMed ID: 24877767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
